Literature DB >> 6375928

A study of the reliability of carcinoembryonic antigen blood levels in following the course of colorectal cancer.

N C Armitage, A Davidson, D Tsikos, C B Wood.   

Abstract

Twenty-three patients were studied to assess the reliability of carcinoembryonic antigen (CEA) levels in following the course of colorectal cancer. CEA estimations were made prior to surgery and again postoperatively. The resected specimens were allocated a Dukes' Stage and histological grading (well, moderate or poorly differentiated). In addition, sections were stained for the presence of CEA by an immunoperoxidase method. Of the 23 patients, twelve had either disseminated disease at initial surgery or subsequently developed metastasis/recurrence. Eleven remain disease-free at a minimum follow-up of one year. In all of these the reliability of plasma CEA values in reflecting the disease status has been assessed. No false positive elevations of CEA were found. Three factors emerge as positive predictors of CEA estimation reliability: pre-operative CEA elevation; tumour grading as well differentiated; dark staining for the presence of CEA. These factors identified 15 of the 18 patients (83%) in whom CEA appeared reliable and were not present in any of the five patients where CEA was not reliable. This reliability achieves statistical significance (X2 = 8.5, p less than 0.02). Histological demonstration of CEA may contribute to the reliability placed on plasma CEA estimations and should be considered if serial estimations are to be performed.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6375928

Source DB:  PubMed          Journal:  Clin Oncol        ISSN: 0305-7399


  4 in total

1.  Carcinoembryonic antigen and recurrent colorectal cancer.

Authors:  J Northover
Journal:  Gut       Date:  1986-02       Impact factor: 23.059

2.  The imprinted H19 gene is a marker of early recurrence in human bladder carcinoma.

Authors:  I Ariel; M Sughayer; Y Fellig; G Pizov; S Ayesh; D Podeh; B A Libdeh; C Levy; T Birman; M L Tykocinski; N de Groot; A Hochberg
Journal:  Mol Pathol       Date:  2000-12

3.  CEA-directed second-look surgery in the asymptomatic patient after primary resection of colorectal carcinoma.

Authors:  E W Martin; J P Minton; L C Carey
Journal:  Ann Surg       Date:  1985-09       Impact factor: 12.969

4.  Combined detection of preoperative serum CEA, CA19-9 and CA242 improve prognostic prediction of surgically treated colorectal cancer patients.

Authors:  Jingtao Wang; Xiao Wang; Fudong Yu; Jian Chen; Senlin Zhao; Dongyuan Zhang; Yang Yu; Xisheng Liu; Huamei Tang; Zhihai Peng
Journal:  Int J Clin Exp Pathol       Date:  2015-11-01
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.